Phase I / Bioequivalence

Our GCP-compliant custom built 360 bed Phase I clinical unit is at the core of our operations. This 115,000 square foot facility is divided into 6 fully-independent clinics. The facility is also self-sustaining, including onsite kitchen, bi-fuel back-up generator for complete clinical operations, and UPS system. Designed to optimize operational efficiency and provide a comfortable environment for the study participants - we have the ideal infrastructure for clinical research studies.

Combined with our team of medical professionals, extensive SOPs, well developing training programs, and innovative technological systems - PMRI has all the tools to offer you world class services.

We have completed over 4000 studies for submission to regulatory agencies around the world and have extensive experience with various dosage forms including:

  • Solid oral
  • Orally inhaled MDI, DPI & Nasal sprays
  • Creams
  • Depot & other Injectables
  • Transdermal patches & Topical products
  • Eye drops
  • Oral suspensions
  • Solutions
Certified Supplier of The Canadian Aboriginal and Minority Supplier Council

We are also fully licensed to run studies with controlled substances

We recognize that dosing a short panel can have a dramatic impact on the success of your study. Pharma Medica has a 99% full panel and on-time recruitment rate, and a 96% average retention rate. Successful subject recruitment and promoting subject compliance (ambulatory blood draws, etc) are top priorities at Pharma Medica.

Through our extensive recruiting and screening database and network of hospital-based partners, we are able to run studies in a variety of special population healthy volunteers and patients:

  • Post-menopausal women
  • Specific cultural or ethnic groups
  • Extensive / Poor metabolizers
  • Obese patients
  • Oncology patients
  • Schizophrenic patients
  • Depressive patients
  • Hyperlipidemic patients

For more information contact: